This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tanaka, T. Articles by Baba, S. Search for Related Content PubMed PubMed Citation Articles by Tanaka, T. Articles by Baba, S.

Prevention of Hepatic Metastasis of Human Colon Cancer by Angiogenesis Inhibitor TNP-470¹

Second Department of Surgery, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu, 431-31 Japan

The antimetastatic effect of a potent angiogenesis inhibitor, O-(chloroacetyl-carbamoyl)fumagillol (TNP-470), was investigated in nude mice implanted with human colon cancer. Small places of tumors from three established human colon cancer cell lines (TK-3, TK-4, and TK-9), which were maintained in nude mice, were implanted into the cecal wall of nude mice via a small incision in the serosa. TNP-470 (20 or 30 mg/kg) was given s.c. every other day from day 10 after implantation, and the mice were sacrificed after 6 weeks.

There was no difference in the weight of the implanted tumors (control group: 0.45 ± 0.29 g versus treated group: 0.49 ± 0.27 g). An antimetastatic effect of TNP-470 was clearly demonstrated in a dose-dependent manner. In the mice given 20 mg/kg TNP-470, liver metastasis developed in 3 of 10 cases. In the 30-mg/kg group, metastasis developed in only 1 of 17 mice, while it developed in 22 of 32 mice of the control group. The number of metastatic foci was significantly less in the treated groups. TNP-470 effectively prevented liver metastasis, however, but had no effect on the growth of the primary tumor. These results indicate that the angiogenesis inhibitor TNP-470 has a strong inhibitory activity against in vivo hepatic metastasis of human colon cancer.

¹ This study was supported by Grant-in-Aid for Scientific Research No. 05671001.

² To whom requests for reprints should be addressed.

Received 7/15/94. Accepted 12/15/94.

This article has been cited by other articles:

				S. Kondo, N. Tanaka, S. Kubota, Y. Mukudai, G. Yosimichi, T. Sugahara, and M. Takigawa Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells Mol. Cancer Ther., January 1, 2006; 5(1): 129 - 137. [Abstract] [Full Text] [PDF]

				M. Muramaki, H. Miyake, I. Hara, and S. Kamidono Introduction of Midkine Gene into Human Bladder Cancer Cells Enhances Their Malignant Phenotype But Increases Their Sensitivity to Antiangiogenic Therapy Clin. Cancer Res., November 1, 2003; 9(14): 5152 - 5160. [Abstract] [Full Text] [PDF]

				K. Inoue, M. Chikazawa, S. Fukata, C. Yoshikawa, and T. Shuin Docetaxel Enhances the Therapeutic Effect of the Angiogenesis Inhibitor TNP-470 (AGM-1470) in Metastatic Human Transitional Cell Carcinoma Clin. Cancer Res., February 1, 2003; 9(2): 886 - 899. [Abstract] [Full Text] [PDF]

				K. Inoue, M. Chikazawa, S. Fukata, C. Yoshikawa, and T. Shuin Frequent Administration of Angiogenesis Inhibitor TNP-470 (AGM-1470) at an Optimal Biological Dose Inhibits Tumor Growth and Metastasis of Metastatic Human Transitional Cell Carcinoma in the Urinary Bladder Clin. Cancer Res., July 1, 2002; 8(7): 2389 - 2398. [Abstract] [Full Text] [PDF]

				A. M. Joussen, W.-D. Beecken, Y. Moromizato, A. Schwartz, B. Kirchhof, and V. Poulaki Inhibition of Inflammatory Corneal Angiogenesis by TNP-470 Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2510 - 2516. [Abstract] [Full Text] [PDF]

				F. Bentzien, I. Struman, J.-F. Martini, J. Martial, and R. Weiner Expression of the Antiangiogenic Factor 16K hPRL in Human HCT116 Colon Cancer Cells Inhibits Tumor Growth in Rag1-/- Mice Cancer Res., October 1, 2001; 61(19): 7356 - 7362. [Abstract] [Full Text] [PDF]

				K. Murakami, R. Sakukawa, M. Sano, A. Hashimoto, J. Shibata, Y. Yamada, and I. Saiki Inhibition of Angiogenesis and Intrahepatic Growth of Colon Cancer by TAC-101 Clin. Cancer Res., September 1, 1999; 5(9): 2304 - 2310. [Abstract] [Full Text] [PDF]

				S. Liekens, E. Verbeken, M. Vandeputte, E. De Clercq, and J. Neyts A Novel Animal Model for Hemangiomas: Inhibition of Hemangioma Development by the Angiogenesis Inhibitor TNP-470 Cancer Res., May 1, 1999; 59(10): 2376 - 2383. [Abstract] [Full Text] [PDF]

				L. Placidi, E. C. Scott, G. de Sousa, R. Rahmani, M. Placidi, and J.-P. Sommadossi Interspecies Variability of TNP-470 Metabolism, Using Primary Monkey, Rat, and Dog Cultured Hepatocytes Drug Metab. Dispos., January 1, 1997; 25(1): 94 - 99. [Abstract] [Full Text]